Lupin Limited has informed the Exchange regarding a press release dated December 29, 2025, titled "Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist".
Press Release Dec 29 2025
Filed with NSE · · 3 pages · English
Release
Earlier from Lupin
- Press Release Dec 18 2025
- Press Release Dec 17 2025
- Press Release Dec 16 2025
- Press Release Dec 12 2025
- Press Release Dec 05 2025
Later from Lupin
- Lupin Limited Press Release Jan 21 2026
- Press Release Jan 23 2026
- Lupin Limited Press Release Feb 02 2026
- Lupin Launches Dasatinib Tablets in the United States
- Lupin Receives Highest ESG Rating from CDP for Climate Change and Water Security
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin